» Articles » PMID: 17761499

High Rates of Resistance to Colistin and Polymyxin B in Subgroups of Acinetobacter Baumannii Isolates from Korea

Overview
Date 2007 Sep 1
PMID 17761499
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals.

Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method.

Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively).

Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.

Citing Articles

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant Infections-A Meta-Analysis.

Huang C, Lin L, Kuo S Antibiotics (Basel). 2024; 13(9).

PMID: 39335080 PMC: 11428705. DOI: 10.3390/antibiotics13090907.


Carbapenem Resistance in Complex Isolates From Kathmandu Model Hospital, Nepal, Is Attributed to the Presence of and Genes.

Gurung A, Napit R, Shrestha B, Lekhak B Biomed Res Int. 2024; 2024:8842625.

PMID: 39161641 PMC: 11333142. DOI: 10.1155/2024/8842625.


Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin.

Baltogianni M, Dermitzaki N, Kosmeri C, Serbis A, Balomenou F, Giapros V Antibiotics (Basel). 2024; 13(4).

PMID: 38667009 PMC: 11047481. DOI: 10.3390/antibiotics13040333.


A Review of Resistance to Polymyxins and Evolving Mobile Colistin Resistance Gene () among Pathogens of Clinical Significance.

Shahzad S, Willcox M, Rayamajhee B Antibiotics (Basel). 2023; 12(11).

PMID: 37998799 PMC: 10668746. DOI: 10.3390/antibiotics12111597.


Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia.

Babaei S, Pourabdollah M, Aslanimehr M, Nikkhahi F, Mahmoodian S, Hasani Y Tanaffos. 2022; 20(4):345-352.

PMID: 36267923 PMC: 9577206.